DE69009887T2 - Bizyklische Derivate. - Google Patents

Bizyklische Derivate.

Info

Publication number
DE69009887T2
DE69009887T2 DE69009887T DE69009887T DE69009887T2 DE 69009887 T2 DE69009887 T2 DE 69009887T2 DE 69009887 T DE69009887 T DE 69009887T DE 69009887 T DE69009887 T DE 69009887T DE 69009887 T2 DE69009887 T2 DE 69009887T2
Authority
DE
Germany
Prior art keywords
bizarre
derivatives
bizarre derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69009887T
Other languages
English (en)
Other versions
DE69009887D1 (de
Inventor
Thomas Geoffrey Colerick Bird
John Francis Kingston
David Waterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca SAS
Imperial Chemical Industries Ltd
Original Assignee
ICI Pharma SA
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICI Pharma SA, Imperial Chemical Industries Ltd filed Critical ICI Pharma SA
Publication of DE69009887D1 publication Critical patent/DE69009887D1/de
Application granted granted Critical
Publication of DE69009887T2 publication Critical patent/DE69009887T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
DE69009887T 1989-07-26 1990-07-23 Bizyklische Derivate. Expired - Fee Related DE69009887T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89402127 1989-07-26

Publications (2)

Publication Number Publication Date
DE69009887D1 DE69009887D1 (de) 1994-07-21
DE69009887T2 true DE69009887T2 (de) 1994-09-22

Family

ID=8202979

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69009887T Expired - Fee Related DE69009887T2 (de) 1989-07-26 1990-07-23 Bizyklische Derivate.

Country Status (5)

Country Link
US (1) US5126365A (de)
EP (1) EP0410661B1 (de)
JP (1) JPH03128373A (de)
DE (1) DE69009887T2 (de)
ES (1) ES2057415T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254581A (en) * 1990-06-21 1993-10-19 Imperial Chemical Industries Plc Pyran derivatives and their use as inhibitors of 5-lipoxygenase
IE914005A1 (en) * 1990-12-14 1992-06-17 Zeneca Ltd Novel intermediates
CA2058254A1 (en) * 1991-01-15 1992-07-16 John Francis Kingston Benzodioxole derivatives
EP0505122A1 (de) * 1991-03-21 1992-09-23 Zeneca Limited Alpha, Alpha-Dialkylbenzylderivate
GB9122590D0 (en) * 1991-10-24 1991-12-04 Lilly Industries Ltd Pharmaceutical compounds
DE19547699C2 (de) * 1995-12-20 2000-01-13 Forschungszentrum Juelich Gmbh Bipolare Platte mit selektiver Beschichtung
CA2401489A1 (en) * 2000-03-02 2001-09-07 Ichiro Miki Oxygen-containing heterocyclic compounds
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2434856A (en) * 1944-10-04 1948-01-20 Forge Frederick B La Tetrahydropyran compound
US3743737A (en) * 1970-05-21 1973-07-03 Smith Kline French Lab 3-sulfonamido-4-hydroxyphenyl-2-piperindinylcarbinol compositions
US3661917A (en) * 1970-05-21 1972-05-09 Smith Kline French Lab 3-sulfonamido-4-hydroxyphenyl-2-piperidylcarbinols
US3795740A (en) * 1972-01-20 1974-03-05 Stauffer Chemical Co Methylene dioxy benzene derivatives as synergists for carbaryl
GB1369379A (en) * 1972-04-07 1974-10-09 Science Union & Cie Benzodioxole derivatives and processes for preparing them
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds
US4567184A (en) * 1982-12-01 1986-01-28 Usv Pharmaceutical Corporation Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies
US4794188A (en) * 1982-12-01 1988-12-27 Usv Pharmaceutical Corporation Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4725619A (en) * 1985-04-16 1988-02-16 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4728668A (en) * 1985-04-16 1988-03-01 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4876346A (en) * 1985-05-02 1989-10-24 American Home Products Corporation Quinoline compounds
EP0271287A3 (de) * 1986-12-11 1990-06-13 Merck Frosst Canada Inc. Chinolindicarbonsäuren und ihre Amide
US4920133A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920130A (en) * 1987-11-02 1990-04-24 Rorer Pharamceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920131A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4918081A (en) * 1988-06-20 1990-04-17 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene d4
EP0349062A1 (de) * 1988-06-27 1990-01-03 Merck Frosst Canada Inc. Chinolinetheralkansäuren

Also Published As

Publication number Publication date
JPH03128373A (ja) 1991-05-31
EP0410661B1 (de) 1994-06-15
DE69009887D1 (de) 1994-07-21
US5126365A (en) 1992-06-30
EP0410661A3 (en) 1991-07-24
EP0410661A2 (de) 1991-01-30
ES2057415T3 (es) 1994-10-16

Similar Documents

Publication Publication Date Title
NO903190L (no) Fremgangsmaate for klorering av sukrose-b-estere.
FI901666A0 (fi) Anordning foer behandling av byggdelar med en gripanordning.
DE69008682D1 (de) Guanidinobenzolderivate.
ATE124407T1 (de) Chromanderivate.
DE69022965T2 (de) Aminopiperazinderivate.
DE59005241D1 (de) Indolderivate.
ATE119146T1 (de) Substituierte bicycloheptadionderivate.
DE69002024D1 (de) Bioaktive laktoferrin derivate.
ATE99694T1 (de) Antiparasitaere derivate.
ATE116985T1 (de) Chromanderivate.
FI902336A0 (fi) Anordning foer framstaellning av en fristaoende kiselkristall.
DE69009887T2 (de) Bizyklische Derivate.
DE69017657D1 (de) Pyridinderivate.
ATE102624T1 (de) Makrolide derivate.
DE59000510D1 (de) N-phenyltetrahydroindazolderivate.
DE69005904T2 (de) Phenylpyrimidonderivate.
DE69019217D1 (de) Perylenquinon (UCN-1028D)-Derivate.
DE69011268T2 (de) Diflourobenzonitril Derivate.
DE59003499D1 (de) 3-Cyano-4-phenyl-pyrrol-Derivate.
DE59105769D1 (de) Alkyloxypropenyl Derivate.
NO905381D0 (no) Sigarett.
DE69015726D1 (de) Piperidylthiocarbapenem-Derivate.
NO892714D0 (no) Substituerte azacykloheksylderivater.
DE69004991D1 (de) Diphenyldiacetylenderivate.
DE69001450D1 (de) Dihydroxynaphthalin-derivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee